Welcome to the HER2-Targeted Therapies Summit

This is the key in-person meeting for any research team developing HER2-centred therapeutics, in either monotherapy or in combination, to revolutionize treatment options for patients. If you are a research team striving to create best-in-class HER2 therapeutics, this is ONLY networking forum that has been curated with you in mind.

This meeting is dedicated to:

Accessing the HER2-targeting potential in CNS metastasis and CRC | Diving into more novel drug modalities than before | Exploring further content on HER2 in cancer indications beyond breast cancer | Basket trial designs | The hottest drugs in early clinical development | How innovation in this competitive space feeds into one of the largest areas of booming development and progress in oncology right now

View the full agenda details now

New For 2022 – Pre-Conference Workshop Day

The new pre-conference workshop day will cover exclusive additional content focusing specifically on accessing the HER2-targeting potential in areas of vast unmet clinical need.

Join workshop leaders from Massachusetts General Hospital Cancer Center, Cedars-Sinai and National Brain Tumor Society to cover topics including understanding pathology and exploiting HER2-targeting in colorectal cancer and CNS metastasis.

View the full agenda details now

What will we cover?

  • Current progress in targeting HER2 as a pan-tumor target
  • Progress in the HER2 expression quantification debate and how current leaders are overcoming challenges in tumor heterogeneity to improve patient stratification
  • Rationale and updates in combination strategy, addressing resistance and metastasis, and novel targeting mechanisms
  • Optimizing basket trial design, treatment regimes and the safety/potency balance of your HER2 drugs
  • Networking in-person with your peers, ask your burning questions, build connections, and fully immerse yourself in the world of HER2

View the full agenda details now